Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT00593242 : Cord Blood for Neonatal Hypoxic-ischemic Encephalopathy
PhasePhase 1
AgesMin: N/A Max: 14 Days
Eligibility
Inclusion Criteria:

- Mothers must have consented for cord blood collection at delivery

- cord blood must be available for extraction of stem cells.

- >34 weeks gestation

- cord or neonatal pH<7.0 or base deficit>16 milliequivalents per liter (mEq/L) or
history of acute perinatal event

- either a 10 minute Apgar < 5 or continued need for ventilation.

- All infants must have signs of encephalopathy within 6 hours of age.

Exclusion Criteria:

- Inability to enroll by 14 days of age.

- Presence of known chromosomal anomaly.

- Presence of major congenital anomalies.

- Severe intrauterine growth restriction (weight <1800g)

- Infants in extremis for whom no additional intensive therapy will be offered by
attending neonatologist.

- Parents refuse consent.

- Attending neonatologist refuses consent.

- Failure to collect the infant's cord blood and/or laboratory unable to process cord
blood.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT00593242      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740